Your browser doesn't support javascript.
loading
Molecular therapies and precision medicine for hepatocellular carcinoma.
Llovet, Josep M; Montal, Robert; Sia, Daniela; Finn, Richard S.
Affiliation
  • Llovet JM; Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Josep.Llovet@mssm.edu.
  • Montal R; Liver Cancer Translational Lab, Barcelona Clinic Liver Cancer (BCLC) Group, Liver Unit, Hospital Clinic Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain. Josep.Llovet@mssm.edu.
  • Sia D; Liver Cancer Translational Lab, Barcelona Clinic Liver Cancer (BCLC) Group, Liver Unit, Hospital Clinic Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Finn RS; Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Nat Rev Clin Oncol ; 15(10): 599-616, 2018 10.
Article in En | MEDLINE | ID: mdl-30061739

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Precision Medicine / Molecular Targeted Therapy / Liver Neoplasms Type of study: Prognostic_studies / Screening_studies Limits: Humans Language: En Journal: Nat Rev Clin Oncol Journal subject: NEOPLASIAS Year: 2018 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Precision Medicine / Molecular Targeted Therapy / Liver Neoplasms Type of study: Prognostic_studies / Screening_studies Limits: Humans Language: En Journal: Nat Rev Clin Oncol Journal subject: NEOPLASIAS Year: 2018 Document type: Article Affiliation country: Country of publication: